Gene Z. Salkind serves as Executive at Cure Pharmaceutical Holding Corp., where they oversee executive responsibilities. Since joining the company, Gene Z. Salkind has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 23, 2022 involved exercising options for 117,647 shares valued at $31.8K.
Gene Z. Salkind currently holds 117,647 shares of Cure Pharmaceutical Holding Corp. (CURR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gene Z. Salkind has been a net neutral trader of CURR stock. They have purchased $0 and sold $0 worth of shares.
Gene Z. Salkind's most recent insider trade was on Sep 23, 2022, when they sold 117,647 shares at $0.27 per share.
Get notified when new Form 4 filings are submitted
| 50,000 |
| $N/A |
| Discretionary |
| Aug 19, 2020 | CURR | $0 | Award | 100,000 | $N/A | Discretionary |
| Feb 15, 2019 | CURR | $0 | Award | 1,621,877 | $N/A | Discretionary |
| Jan 1, 2019 | CURR | $0 | Award | 250,000 | $N/A | Discretionary |